Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: How much progress has been made?

John T. Horan, Brent R. Logan, Manza A. Agovi-Johnson, Hillard M. Lazarus, Andrea A. Bacigalupo, Karen K. Ballen, Christopher N. Bredeson, Matthew H. Carabasi, Vikas Gupta, Gregory A. Hale, Hanna Jean Khoury, Mark B. Juckett, Mark R. Litzow, Rodrigo Martino, Philip L. McCarthy, Franklin O. Smith, J. Douglas Rizzo, Marcelo C. Pasquini

Research output: Contribution to journalArticle

123 Scopus citations

Abstract

Purpose: Transplantation-related mortality (TRM) is a major barrier to the success of allogeneic hematopoietic cell transplantation (HCT). Patients and Methods: We assessed changes in the incidence of TRM and overall survival from 1985 through 2004 in 5,972 patients younger than age 50 years who received myeloablative conditioning and HCT for acute myeloid leukemia (AML) in first complete remission (CR1) or second complete remission (CR2). Results: Among HLA-matched sibling donor transplantation recipients, the relative risks (RRs) for TRM were 0.5 and 0.3 for 2000 to 2004 compared with those for 1985 to 1989 in patients in CR1 and CR2, respectively (P < .001). The RRs for all causes of mortality in the latter period were 0.73 (P < .001) and 0.60 (P < .005) for the CR1 and CR2 groups, respectively. Among unrelated donor transplantation recipients, the RRs for TRM were 0.73 (P = .095) and 0.58 (P < .001) for 2000 to 2004 compared with those in 1990 to 1994 in the CR1 and CR2 groups, respectively. Reductions in mortality were observed in the CR2 group (RR, 0.74; P = .03) but not in the CR1 group. Conclusion: Our results suggest that innovations in transplantation care since the 1980s and 1990s have reduced the risk of TRM in patients undergoing allogeneic HCT for AML and that this reduction has been accompanied by improvements in overall survival.

Original languageEnglish (US)
Pages (from-to)805-813
Number of pages9
JournalJournal of Clinical Oncology
Volume29
Issue number7
DOIs
StatePublished - Mar 1 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: How much progress has been made?'. Together they form a unique fingerprint.

  • Cite this

    Horan, J. T., Logan, B. R., Agovi-Johnson, M. A., Lazarus, H. M., Bacigalupo, A. A., Ballen, K. K., Bredeson, C. N., Carabasi, M. H., Gupta, V., Hale, G. A., Khoury, H. J., Juckett, M. B., Litzow, M. R., Martino, R., McCarthy, P. L., Smith, F. O., Rizzo, J. D., & Pasquini, M. C. (2011). Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: How much progress has been made? Journal of Clinical Oncology, 29(7), 805-813. https://doi.org/10.1200/JCO.2010.32.5001